We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+2.31%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$720M
AUM Growth
-$214M
Cap. Flow
-$176M
Cap. Flow %
-24.45%
Top 10 Hldgs %
53.82%
Holding
93
New
36
Increased
15
Reduced
13
Closed
19

Top Buys

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$16.4M
2
BIIB icon
Biogen
BIIB
+$11.8M
3
ADBE icon
Adobe
ADBE
+$11M
4
PANW icon
Palo Alto Networks
PANW
+$10.9M
5
KRNT icon
Kornit Digital
KRNT
+$9.29M

Top Sells

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$32.5M
2
FIVN icon
FIVE9
FIVN
+$12.8M
3
ALT icon
Altimmune
ALT
+$11.7M
4
NICE icon
Nice
NICE
+$10.9M
5
JNJ icon
Johnson & Johnson
JNJ
+$10.2M

Sector Composition

Rank Sector Weight
1 Healthcare 66.02%
2 Technology 7.17%
3 Industrials 1.19%
4 Consumer Discretionary 1.16%
5 Communication Services 1.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QQQ icon
1
PUT
Invesco QQQ Trust
QQQ
$453B
$87M 12.07%
+325,500
New +$98.2M
AZN icon
2
AstraZeneca
AZN
$263B
$49.2M 6.83%
448,530
+49,225
+12% +$6.24M
LLY icon
3
Eli Lilly
LLY
$1.02T
$46.4M 6.44%
143,550
+11,300
+9% +$3.58M
SNY icon
4
Sanofi
SNY
$103B
$46.2M 6.41%
1,214,515
+368,300
+44% +$16.4M
JNJ icon
5
Johnson & Johnson
JNJ
$618B
$35.3M 4.9%
216,151
-60,300
-22% -$10.2M
MRK icon
6
Merck
MRK
$322B
$31.6M 4.39%
367,000
+82,000
+29% +$7.32M
NVO
7
Novo Nordisk
NVO
$208B
$29.5M 4.1%
592,880
+70,000
+13% +$3.75M
ABBV icon
8
AbbVie
ABBV
$443B
$21.8M 3.02%
162,285
-56,100
-26% -$8.05M
NVDA icon
9
CALL
NVIDIA
NVDA
$4.86T
$21M 2.91%
+1,726,000
New +$27.3M
SNDX icon
10
Syndax Pharmaceuticals
SNDX
$1.69B
$19.8M 2.74%
822,696
-316,633
-28% -$7.1M
TEVA icon
11
CALL
Teva Pharmaceuticals
TEVA
$40.8B
$17.8M 2.48%
2,210,000
-1,171,600
-35% -$10.4M
BIIB icon
12
Biogen
BIIB
$30B
$14.8M 2.06%
+55,500
New +$11.8M
CRNX icon
13
Crinetics Pharmaceuticals
CRNX
$8.84B
$12.3M 1.71%
626,552
+39,732
+7% +$810K
U icon
14
CALL
Unity
U
$13.8B
$11.7M 1.63%
+367,500
New +$15.1M
KURA icon
15
Kura Oncology
KURA
$800M
$10.8M 1.5%
789,952
+295,357
+60% +$4.56M
KZR
16
DELISTED
Kezar Life Sciences
KZR
$10.7M 1.49%
124,581
+94,616
+316% +$9.19M
KDNY
17
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$10.5M 1.46%
534,358
-109,373
-17% -$2.19M
ISEE
18
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$10.4M 1.45%
581,829
-380,641
-40% -$5M
PANW icon
19
Palo Alto Networks
PANW
$270B
$10.3M 1.43%
+126,000
New +$10.9M
WIX icon
20
WIX.com
WIX
$2.3B
$10.1M 1.4%
+129,000
New +$8.89M
SWTX
21
DELISTED
SpringWorks Therapeutics
SWTX
$8.61M 1.19%
301,625
-235,039
-44% -$6.74M
KRNT icon
22
Kornit Digital
KRNT
$705M
$8.59M 1.19%
+322,926
New +$9.29M
GLBE icon
23
Global E Online
GLBE
$6.6B
$8.34M 1.16%
+311,460
New +$8.87M
PNT
24
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$8.14M 1.13%
+1,052,842
New +$8.94M
ADBE icon
25
Adobe
ADBE
$99.5B
$8.02M 1.11%
+29,150
New +$11M
1
2 3 4

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q3 2022 Portfolio in Review

As of Q3 2022, Sphera Funds Management held 93 positions worth $720M, down 23% from $935M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Sphera Funds Management withdrew a net $176M in Q3 2022, closing 19 positions and reducing 13 holdings. Its most notable exit was State Street SPDR S&P Biotech ETF, an estimated $32.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, up from 47% a quarter earlier, followed by Technology and Industrials.

Against the trend, Sphera Funds Management opened a new position in Biogen worth $14.8M.

  • Sphera Funds Management's largest Q3 2022 buy was Biogen: 55,500 shares worth $14.8M.
  • Sphera Funds Management added most to Sanofi in Q3 2022, an estimated $16.4M increase.
  • Sphera Funds Management's biggest Q3 2022 reduction was Altimmune, cutting an estimated $11.7M.
  • Sphera Funds Management fully exited State Street SPDR S&P Biotech ETF in Q3 2022, selling an estimated $32.5M.
  • Sphera Funds Management's ten largest holdings make up 54% of its $720M portfolio in Q3 2022.
  • Sphera Funds Management opened 36 new positions and closed 19 in Q3 2022.
  • Sphera Funds Management's portfolio value fell 23% quarter-over-quarter to $720M.

Based on Sphera Funds Management's 13F filing for Q3 2022, filed 14 Nov 2022.